Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2026-03-04Clinical Trial Update: Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Clinical trial update notes dyspnea and cardiotoxicity in multiple myeloma patients treated with carfilzomib, with the study subsequently te…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA) [Phase 3]
A Phase 3 clinical trial update comparing KRd (carfilzomib, lenalidomide, dexamethasone) versus VRd (bortezomib, lenalidomide, dexamethasone…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma [Phase 2]
Phase 2 study evaluating the efficacy and safety of bb2121 in relapsed/refractory and high-risk multiple myeloma has completed, with reporte…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Ninlaro in Real World Clinical Practice in China
A completed real-world study evaluating Ninlaro (ixazomib) in Chinese clinical practice for multiple myeloma. The study analyzes how the dru…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101 [Phase 1]
Long-term follow-up data are being collected for subjects treated with P-BCMA-101 in a Phase 1 study for multiple myeloma. The trial status …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors [Phase 1]
A Phase 1 clinical trial update for a CD70-targeted CAR T therapy (CD70.CAR) in CD70-positive lymphoma, multiple myeloma, solid tumors, sarc…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Investigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
This clinical trial entry describes an ongoing study investigating how N-glycosylation contributes to AL amyloidosis, including its molecula…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma [Phase 3]
Phase 3 clinical trial update comparing a carfilzomib-containing regimen (carfilzomib, lenalidomide, dexamethasone) versus lenalidomide alon…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating BCMA-targeted CAR T cells with or without lenalidomide for multiple myeloma; currently active but not recr…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies [Phase 1]
A Phase 1 study evaluating feasibility and safety of collecting autologous hematopoietic stem cells and combining them with CAR T-cell thera…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy [Phase 2]
Phase 2 study evaluating talquetamab in people with multiple myeloma who have previously received BCMA CAR T-cell therapy is currently recru…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Discontinuation Study [NA]
University College Cork is conducting a Discontinuation Study for conditions including multiple myeloma; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma [Phase 2]
A Phase 2 clinical trial investigating multi-immune, multi-target immunotherapy for high-risk multiple myeloma is planned but not yet recrui…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Feasibility of a Multi-omics Platform for Hematological Malignancies [NA]
This clinical trial update assesses the feasibility of a multi-omics platform for hematological malignancies and is currently recruiting. It…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of Oral LOXO-338 in Patients With Advanced Blood Cancers [Phase 1]
Phase 1 study of oral LOXO-338 in advanced blood cancers is ongoing, with status listed as active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease [NA]
This entry describes the FAST-M trial evaluating prolonged overnight fasting with a Mediterranean diet for patients with multiple myeloma or…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment [NA]
A clinical trial evaluating a PREHABilitation protocol using Adapted Physical Activity for multiple myeloma patients eligible for intensive …
-
CLINICAL_TRIALS trial_result · 2026-03-02Clinical Trial Update: Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating response-adapted initial therapy for multiple myeloma using bortezomib/dexamethasone, with lenalidomide added for n…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Karyopharm Expanded Access Program for Selinexor
This update covers Karyopharm's Expanded Access Program for selinexor (Xpovio), including eligibility and current availability for listed ca…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
This clinical trial update reports on outcomes of maintenance therapy following autologous stem cell transplantation in patients with multip…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients [Phase 1, Phase 2]
A Phase 1/2 trial in China is evaluating BCMA-CART with or without autologous stem cell transplant in young patients with multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Biomarkers of AKI in Patients Receiving Daratumumab
A completed clinical trial update investigating biomarkers of acute kidney injury in patients treated with daratumumab for multiple myeloma,…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma [Phase 2]
This is a Phase 2 clinical trial update for SELIBORDARA, evaluating a triplet of selinexor, bortezomib, and daratumumab in refractory multip…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: CAR BCMA-70 CAR-T Cells for the Treatment of High-risk Plasma Cell Neoplasms [EARLY_Phase 1]
A Phase 1 clinical trial evaluating CAR BCMA-70 CAR-T cells for high-risk plasma cell neoplasms is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma [Phase 1]
Phase 1 trial evaluating tumor-associated antigen-specific cytotoxic T-lymphocytes for multiple myeloma is currently recruiting.